Sjögren syndrome is an autoimmune disease characterized by targeted destruction of the lacrimal and salivary glands resulting in symptoms of severe ocular and oral dryness. Despite its prevalence, the mechanisms driving autoimmune manifestations are unclear. In patients and in the nonobese diabetic (NOD) mouse model of Sjögren syndrome, lymphocytic infiltrates consist of CD4 and CD8 T cells, although the role of CD8 T cells in disease pathogenesis has been largely unexplored. Here, we evaluated the contribution of CD8 T cells to lacrimal and salivary gland autoimmunity. Within the lacrimal and salivary glands of NOD mice, CD8 T cells were proliferating, expressed an activated phenotype, and produced inflammatory cytokines. Transfer of purified CD8 T cells isolated from the cervical lymph nodes (LNs) of NOD mice into NOD-severe combined immunodeficiency recipients resulted in inflammation of the lacrimal glands, but was not sufficient to cause inflammation of the salivary glands. Lacrimal gland-infiltrating CD8 T cells displayed a cytotoxic phenotype, and epithelial cell damage in the lacrimal glands was observed in recipients of CD8 T cells regardless of the presence of CD4 T cells. Collectively, our results demonstrate that CD8 T cells have a pathogenic role in lacrimal gland autoimmunity. The gland-specific pathogenicity of CD8 T cells makes them a valuable resource to further understand the mechanisms that discriminate lacrimal versus salivary gland autoimmunity and for the development of new therapeutics that target the early stages of disease.
Sjögren syndrome is a complex autoimmune disease characterized by targeted immune destruction of the lacrimal and salivary glands. Damage to the glands leads to the loss of appropriate tear and saliva production resulting in symptoms of severe dry eyes and mouth that decrease quality of life and cause considerable morbidity. 1 In addition, other organs may be targeted by the aberrant immune response, and patients with Sjögren syndrome have an increased risk of developing lymphoma. 2 Despite the high prevalence of disease, the etiology of Sjögren syndrome is poorly understood, in part due to the difficulty in studying the early cellular events, which arise years before clinical symptoms. 3 The nonobese diabetic (NOD) mouse spontaneously develops lacrimal and salivary gland autoimmunity, and is a well-characterized model of Sjögren syndrome. 4, 5 In NOD mice, sex-specific differences in gland inflammation have been described, with male mice developing spontaneous lacrimal gland inflammation (dacryoadenitis) and female mice developing spontaneous salivary gland inflammation (sialadenitis). [6] [7] [8] [9] [10] Lymphocytic infiltrates isolated from the lacrimal and salivary glands of humans and NOD mice are composed largely of CD4 T cells, yet CD8 T cells are consistently present. [11] [12] [13] [14] [15] [16] In a variety of other autoimmune diseases, CD8 T cells contribute to the initiation, progression or regulation of disease and, depending on the context, both pathogenic and regulatory roles have been described. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] However, the role of CD8 T cells in lacrimal or salivary gland autoimmunity is not known.
Here, we evaluate the phenotype of CD8 T cells in lacrimal and salivary gland infiltrates in NOD mice and use a previously described adoptive transfer model 6 to dissect the roles of CD8 T cells in lacrimal and salivary gland autoimmunity.
RESULTS

Activated CD8 T cells are present in lacrimal and salivary gland infiltrates
To determine the role of CD8 T cells in lacrimal and salivary gland autoimmunity, we characterized CD8 T cells isolated from the lacrimal and salivary glands of male and female NOD mice, respectively. As demonstrated previously, 12 the frequencies of CD4 and CD8 T cells were similar in infiltrates from lacrimal and salivary glands, with CD4 T cells constituting the majority of T cells in each gland, but with a population of CD8 T cells always present (Figure 1a ). We assessed these CD8 T cells in gland infiltrates for the expression of surface activation markers and production of cytokines (Figure 1b ). This included analysis of the integrin CD11a, which has a role in T-cell costimulation 31, 32 and is upregulated on CD8 T cells after antigen stimulation, 33 thus serving as a surrogate marker for T-cell activation. We also examined cell surface expression of CD69, which is upregulated as a result of T-cell stimulation through the T-cell receptor, 34 or in the presence of inflammatory signals (e.g., interferon-α/β (IFN-α/β)). 35 In both lacrimal and salivary glands, the majority of CD8 T cells expressed CD11a, while a large subset also expressed CD69 (Figure 1b) . A subset of CD8 T cells isolated from the glands was actively proliferating based on Ki67 staining (Figure 1b) . The majority of CD8 T cells produced IFNγ upon stimulation, and a subset of these coproduced tumor necrosis factor-α (Figure 1b) . Similarly, lacrimal and salivary gland-infiltrating CD4 T cells expressed an activated phenotype, were proliferating and produced IFNγ and tumor necrosis factor-α following stimulation (Figure 1c ). Thus, the majority of CD8 and CD4 T cells in lacrimal and salivary gland infiltrates displayed an activated phenotype and were capable of producing inflammatory cytokines.
CD8 T cells promote dacryoadenitis, but not sialadenitis
To determine the pathogenicity of CD8 T cells in the context of lacrimal and salivary gland autoimmunity, we tested their ability to promote the development of dacryoadenitis or sialadenitis. To address this question, we used our previously established adoptive transfer model of Sjögren syndrome in which the transfer of cervical lymph node (LN) cells into sex-matched recipients results in gland inflammation similar to that observed in spontaneous disease 6 (and manuscript in preparation). CD8 T cells were purified (496% of total cells and 498% of T cells) from cervical LN of male or female NOD mice and transferred into sex-matched NOD-severe combined immunodeficiency (NOD-SCID) recipients (Figure 2a ). As a comparison, we transferred purified CD8 T cells that were recombined with the CD8-depleted population (non-CD8+CD8) into sex-matched NOD-SCID recipient mice. Five weeks after transfer, the degree of dacryoadenitis or sialadenitis was assessed. In male recipients, a similar level of dacryoadenitis developed in mice that received CD8-only cells relative to mice that received non-CD8+CD8 cells, with some mice in the CD8-only group developing diffuse inflammation (Figure 2b and Supplementary Figure 1a ). While low levels of sialadenitis were observed in some recipients of non-CD8 +CD8 cells, sialadenitis was not observed in male recipients of CD8only cells (Figure 2b and Supplementary Figure 1b ). In the NOD mouse model, male mice spontaneously develop dacryoadenitis, whereas a greater degree of sialadenitis develops in female NOD mice. 8, 9 Therefore, we determined if CD8 T cells could promote sialadenitis in female mice. Strikingly, while female recipients of non-CD8+CD8 cells developed sialadenitis, we did not detect sialadenitis in any female NOD-SCID recipients of CD8-only cells, despite the fact that some of these recipients developed dacryoadenitis (Figure 2c and Supplementary Figures 1c and d) . Collectively, these data suggest that CD8 T cells can independently promote the development of dacryoadenitis in male NOD mice but not sialadenitis in female NOD mice.
Flow cytometric analyses of cervical LN cells in recipient mice 5 weeks after transfer confirmed that recipients of CD8-only cells had proportionally more CD8 T cells in the cervical LN relative to mice that received non-CD8+CD8 cells (Figure 2d ). An outgrowth of CD4 T cells was observed in CD8-only recipients, yet this percentage was still significantly reduced relative to the percentage of CD4 T cells present in recipients of non-CD8+CD8 cells (Figure 2d ). The outgrowth of CD4 T cells in the cervical LN of CD8-only recipients included a subset of CD4 + Foxp3 + T-regulatory cells (Tregs) Figure 1 Gland-infiltrating CD8 T cells display an activated phenotype. (a) Representative flow cytometry plots of gland-infiltrating T cells from male lacrimal (top) or female salivary (bottom) glands from 12-17-week-old NOD mice. Plots were gated on live, CD3ε + singlets. Numbers represent the frequency of cells in indicated gate. Graphs depict cumulative quantification of data from at least two independent experiments from male lacrimal (top) or female salivary (bottom) glands, n = 7 per group. Each data point indicates an individual mouse and lines represent the mean. (b) Flow cytometric analyses of gland-infiltrating CD8 T cells from male lacrimal (left) or female salivary (right) glands from mice in a. Plots were gated on live, CD3ε + CD8 + CD4singlets. Numbers represent the frequency of cells in each gate. (c) Flow cytometric analyses of gland-infiltrating CD4 T cells from male lacrimal (left) or female salivary (right) glands from mice in a. Plots were gated on live, CD3ε + CD8 -CD4 + Foxp3singlets. Numbers represent the frequency of cells in each gate. A full color version of this figure is available at the Immunology and Cell Biology journal online.
( Supplementary Figure 2a ). Corresponding to the overall reduction in the percentage of CD4 T cells in CD8-only recipients, the percentage of Tregs within the total T-cell population was also significantly reduced relative to recipients of non-CD8+CD8 cells ( Supplementary  Figure 2a ). However, within the CD4 T-cell population the percentage of Tregs was similar in CD8-only recipients relative to recipients of non-CD8+CD8 cells ( Supplementary Figure 2b ), suggesting that the outgrowth of CD4 T cells in the cervical LN is equivalent for non-Tregs and Tregs. Despite the outgrowth of CD4 T cells in recipients of CD8-only cells, very few B cells were present, whereas recipients of non-CD8+CD8 cells had an appreciable proportion of B cells ( Supplementary Figure 2c ).
Analysis of cell composition in the lacrimal glands similarly showed that CD8 T cells comprised the major cell population in CD8-only recipients, yet the outgrowth of CD4 T cells noted in the cervical LN was also detected within these lacrimal gland infiltrates (Figure 2e ). In recipients of non-CD8+CD8 cells, CD4 T cells constituted the majority of cells in the lacrimal glands, whereas CD8 T cells comprised a small subset of the population (Figure 2e ), similar to the composition observed in spontaneous disease ( Figure 1 ). Notably, the ratio of CD4:CD8 T cells was elevated within the lacrimal glands relative to the cervical LN in mice that received non-CD8+CD8 cells (Figure 2f ), indicating a selectivity for CD4 T cells in the lacrimal glands, similar to that observed when dacryoadenitis develops spontaneously ( Figure 2g ). Although not significant, a similar difference was also observed in recipients of CD8-only cells ( Figure 2f ). However, whether this reflects differential trafficking of CD4 T cells to the lacrimal glands or differential expansion of these cells within the lacrimal glands remains to be determined. Within the total T-cell population in the lacrimal glands, CD4 + Foxp3 + Tregs were also significantly reduced in CD8-only recipients relative to recipients of non-CD8+CD8 cells ( Supplementary Figure 2d ). While not reaching statistical significance, CD4 + Foxp3 + Tregs were reduced within the CD4 + population in CD8-only recipients relative to recipients of non-CD8+CD8 cells ( Supplementary Figure 2e ). This is in contrast to the cervical LN ( Supplementary Figure 2b) , although it is unclear if this is due to differences in the trafficking of CD4 + Foxp3 + cells to the lacrimal glands or their expansion within the glands.
Dacryoadenitis occurs in the absence of CD8 T cells
Despite the presence of activated CD8 T cells in lacrimal gland infiltrates, the outgrowth of CD4 T cells in our CD8-only transfers and selective accumulation of CD4 T cells within lacrimal glands of NOD mice and NOD-SCID recipients suggested CD4 T cells have a key role in the development of dacryoadenitis. To determine if cervical LN cells could mediate lacrimal gland disease in the absence of CD8 T cells, we transferred CD8-depleted cervical LN cells from male NOD donors either alone (non-CD8) or with CD8 T cells added back (non-CD8 +CD8) to sex-matched, NOD-SCID recipient mice. A similar degree of dacryoadenitis developed in recipients of non-CD8 cells and recipients of non-CD8+CD8 cells (Figure 3a 
CD8 and CD4 T cells each contribute to dacryoadenitis
We next assessed the level of spontaneous dacryoadenitis in NOD mice that were deficient for CD8 expression (CD8 null ) or CD4 expression (CD4 null ) and thus lacked CD8 or CD4 T cells, respectively. In contrast to our transfer model, the absence of CD8 T cells resulted in a significant decrease in dacryoadenitis in 11-14-week-old CD8 null mice relative to age-matched wild-type (WT) NOD mice ( Figure 4 ). Dacryoadenitis was also significantly reduced in CD4 null mice relative to WT controls, while no difference in inflammation was observed between CD8 null and CD4 null mice ( Figure 4 ). In contrast, 20-24-week-old CD8 null mice developed increased dacryoadenitis relative to age-matched CD4 null mice, which continued to display decreased dacryoadenitis compared with age-matched WT mice ( Figure 4 ). Further, the degree of inflammation in old CD8 null mice was increased relative to young CD8 null mice, whereas no change was observed between young and old CD4 null mice ( Figure 4 ). For all genotypes, both T and B cells were present in the cervical LN and, as expected, CD8 or CD4 T cells were absent from the cervical LN of CD8 null or CD4 null mice, respectively (Supplementary Figure 4 ). Collectively, these findings suggest that whereas CD8 T cells do not compensate for the lack of CD4 T cells, over time CD4 T cells can compensate for the lack of CD8 T cells in mediating dacryoadenitis.
Although the degree of dacryoadenitis in 11-14-week-old CD8 null and CD4 null mice was reduced relative to WT NOD mice, some inflammation was still observed (i.e., focus score40), which is in contrast to mouse strains that are not prone to lacrimal gland autoimmunity. Specifically, no foci (i.e., focus score = 0) were observed in lacrimal glands of 13-week-old male Balb/c mice (n = 5, data not shown). These data indicate that CD8 and CD4 T cells are independently capable of mediating some degree of lacrimal gland inflammation in NOD mouse strains. Collectively, the reduction in disease severity in the absence of either CD8 or CD4 T cells suggests that both cell types contribute to the early events that promote spontaneous dacryoadenitis.
CD4 T cells are not required for CD8 T-cell-mediated dacryoadenitis
Although the development of some dacryoadenitis in CD4 null mice suggests inflammation in this context is mediated by CD8 T cells, the presence of CD4 − CD8 − TCRαβ + T cells with characteristics of CD4 T cells have been reported in CD4 null mice. 36 Thus, we cannot rule out the potential contribution of these cells to the dacryoadenitis observed in CD4 null mice. Additionally, the consistent outgrowth of CD4 T cells in our CD8-only transfers (Figures 2d-f ) suggested the possibility that CD8 T cells only cause dacryoadenitis in the presence of CD4 T cells. To address this, we transferred purified populations of fluorescenceactivated cell-sorted CD8 T cells from male NOD donors ( Figure 5a ) into sex-matched, NOD-SCID recipients that were treated weekly with anti-CD4 or isotype control antibody. Similar to the outgrowth of CD4 T cells observed in our prior CD8-only transfers, an outgrowth of CD4 T cells was detected at 3 and 5 weeks post transfer in the peripheral blood of recipient mice treated with an isotype control antibody ( Figure 5b ). In contrast, CD4 T cells were undetectable in the blood of mice receiving the anti-CD4 antibody treatment (Figure 5b ), indicating efficient depletion of CD4 T cells. Despite these differences, the degree of dacryoadenitis was similar in mice treated with anti-CD4 antibody relative to those treated with isotype control antibody ( Figure 5c ). The overwhelming majority of cells recovered from the cervical LN or lacrimal glands of anti-CD4 antibody-treated recipients were CD8 T cells, with o0.6% being CD4 T cells (Figures 5d and e ).
Importantly, while the CD4:CD8 ratio again demonstrated an increase in CD4 T cells in the lacrimal glands relative to the cervical LN of isotype antibody-treated recipients, no such accumulation was noted in the lacrimal glands of anti-CD4 antibody-treated recipients (Figure 5f ). Thus, in the absence of an outgrowth of CD4 T cells, CD8 T cells can independently infiltrate the lacrimal glands and promote the development of dacryoadenitis in our transfer model of Sjögren syndrome.
CD8 T cells mediate epithelial cell destruction
The presence of activated, inflammatory cytokine-producing CD8 T cells in the lacrimal glands ( Figure 1 ) and the ability of CD8 T cells to promote the development of dacryoadenitis even in the absence of CD4 T cells ( Figure 5 ) suggest that CD8 T cells have a pathogenic role in lacrimal gland autoimmunity. Upon activation, CD8 T cells differentiate into cytotoxic T cells and kill target cells when their cognate antigen is recognized. 29 To confirm that CD8 T cells in the CD8 T cells promote lacrimal gland autoimmunity JY Barr et al lacrimal glands mediate epithelial cell damage, we assessed epithelial cell apoptosis by staining for activated caspase-3 in lacrimal gland sections from prior recipients of non-CD8+CD8 or CD8-only cells, or from male NOD mice that developed spontaneous dacryoadenitis. Selected recipients with focus scores similar to the median focus score of their respective group were chosen for analysis: non-CD8+CD8 (median focus score: 2.8; range: 2.2-3.2), CD8-only T cells (median focus score: 3.5; range: 1.6-9.2) and male NOD mice with spontaneous dacryoadenitis (median focus score: 8.3; range: 5.0-15.4). Additionally, recipients with no focal inflammation (i.e., focus score = 0) from each of these transfer groups were analyzed to establish baseline levels of activated caspase-3 expression. In the absence of inflammation infrequent activated caspase-3 staining was observed (0.7 activated caspase-3 + cells per mm 2 ± 0.5; n = 3). The total number of activated caspase-3 + cells was increased over baseline levels in non-CD8+CD8 recipient mice with inflammation (2.0 activated caspase-3 + cells per mm 2 ± 2.4; n = 7), in CD8-only recipients with inflammation (4.1 activated caspase-3 + cells per mm 2 ± 2.3; n = 7) and in mice with spontaneous inflammation (3.7 activated caspase-3 + cells per mm 2 ± 1.1; n = 6), although these differences did not reach statistical significance (one-way analysis of variance (ANOVA) P = 0.059). Therefore, to determine if the activated caspase-3 staining observed in the presence of inflammation could be distinguished from that observed in areas not associated with inflammation, we assessed the number of activated caspase-3 + cells based on location: within the inflammatory foci (in), outside the inflammatory foci (out) (Figure 6a ) or in areas of normal tissue (normal) (Figure 6b ). Within each group, more activated caspase-3 + cells were within inflammatory foci than those in the adjacent region outside the inflammation or in areas of normal tissue (Figure 6c ). These data suggested an association of epithelial cell apoptosis with CD8 and CD4 T cells each contribute to the early stages of lacrimal gland autoimmunity. Quantification of inflammation in male lacrimal glands from 11-14-week-old WT (n = 28), CD8 null (n = 14) or CD4 null (n = 15) NOD mice or 20-24-week-old WT (n = 7), CD8 null (n = 20) or CD4 null (n = 10) NOD mice. Symbols represent individual mice, lines represent medians. Significant differences between mouse groups and age groups were identified by two-way ANOVA on focus score ranks (Po0.0001 and Po0.01, respectively) with no significant interaction between the two (P = 0.109). Tukey's honest significant difference post hoc test P-values are shown. *Po0.05, ***Po0.001 and ****Po0.0001. inflammatory foci, which makes biological sense. However, to mitigate potential bias associated with analysis of select areas within tissue sections, we quantified the number of activated caspase-3 + cells from whole tissue sections of glands from recipients of CD8-only cells, recipients of non-CD8+CD8 cells and male NOD mice with spontaneous disease. To confirm our findings above, we compared the total number of activated caspase-3 + cells (normalized to tissue section area) to the total number of foci (normalized to area) quantified from separate hematoxylin and eosin-stained tissue sections for each sample. As expected, these whole-slide analyses demonstrated correlation between cell death and inflammation (Figure 6d ). Taken together, these findings demonstrate that epithelial cell death is associated with lacrimal gland inflammation and suggest that CD8 T cells are capable of mediating lacrimal gland epithelial cell death.
As mice in the CD8-only group included some recipients with CD4 T-cell outgrowth and also those treated with depleting antibody to prevent such outgrowth, we wanted to confirm that the number of activated caspase-3 + cells in CD8-only recipients was not dependent on an outgrowth of CD4 T cells. Thus, we assessed the correlation between the number of activated caspase-3 + cells within areas of inflammation and the percentage of CD4 T cells in the lacrimal gland 5 weeks after transfer. No correlation was observed between the number of activated caspase-3 + cells detected in inflammatory foci and the percentage of CD4 T cells within the gland (Figure 6e ). Thus, these data demonstrate that epithelial cell apoptosis observed in mice with dacryoadenitis is associated with the inflammatory infiltrate in the lacrimal glands and is similar whether CD8 T cells are alone or are accompanied by other cells (e.g., CD4 T cells). 
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One mechanism of cell killing used by CD8 T cells is through the release of cytotoxic granules containing perforin and granzyme B. 37, 38 Release of these molecules is the result of degranulation, which occurs rapidly after cell activation. 38 As a consequence of degranulation, CD8 T cells express the lysosomal-associated membrane glycoprotein CD107a on their surface, and this correlates with cytotoxic activity. 39 Thus, measuring surface expression of CD107a identifies CD8 T cells that have undergone degranulation. To determine if CD8 T cells in the lacrimal glands displayed characteristics of cytotoxic CD8 T cells, we used flow cytometric analyses to assess the expression of CD107a and granzyme B. Assessment of lacrimal gland infiltrates isolated from male NOD mice that developed spontaneous dacryoadenitis demonstrated an increased proportion of CD8 T cells that expressed CD107a after stimulation ex vivo relative to CD8 T cells in the cervical LN (Figure 6f ). Additionally, a smaller but significant increase in the percentage of CD8 T cells producing granzyme B was observed in lacrimal gland infiltrates relative to those from the cervical LN (Figure 6f ). Thus, a subset of CD8 T cells within the lacrimal glands displayed a cytotoxic phenotype. Collectively, these data indicate that CD8 T cells contribute to spontaneous dacryoadenitis and induce apoptosis of lacrimal gland epithelial cells, suggesting a pathogenic role for CD8 T cells in autoimmune dacryoadenitis. (c) Quantification of the number of activated caspase-3 + cells in lacrimal gland sections from NOD mice that spontaneously developed lacrimal gland inflammation (n = 5), or NOD-SCID mice that received CD8-only cells (n = 9) or non-CD8+CD8 cells (n = 4) based on location: within inflammatory foci (in), outside the inflammatory foci (out) or in areas of normal gland tissue (normal). Activated caspase-3 + cells were determined by averaging the values from two images per gland. Symbols represent individual mice, lines are means. P-values determined by two-way ANOVA demonstrates a significant difference between locations (i.e., for each group 'in' is greater than 'out' or 'normal') but no significant difference between groups (P = 0.68) and no significant interaction between group and location (P = 0.34). (d) Correlation between the total number of activated caspase-3 + cells per mm 2 and the number of foci per mm 2 in whole lacrimal gland sections from recipients of CD8-only cells (n = 4), recipients of non-CD8+CD8 cells (n = 4) or male NOD mice with spontaneous disease (n = 5). Symbols represent individual mice. P-and r-values were determined by Spearman's correlation. (e) Correlation between the number of activated caspase-3 + cells within foci and percentage of CD4 T cells in the lacrimal glands of mice that received CD8-only T cells. Symbols represent individual mice. P-and r-values were determined by Pearson's correlation. (f) Flow cytometric analyses of CD8 T cells isolated from the cervical LN or lacrimal glands of 12-16-week-old male NOD mice. Cells were gated on live, CD3ε + CD19 -CD8 + singlets before assessing surface expression of CD107a or staining for intracellular granzyme B. Numbers represent the frequency of cells in each gate. Graphs depict cumulative quantification of data from two independent experiments (n = 6 per group). P-values were determined by unpaired Student's t-test. A full color version of this figure is available at the Immunology and Cell Biology journal online.
CD8 T cells promote lacrimal gland autoimmunity
JY Barr et al DISCUSSION CD8 T cells contribute to disease pathogenesis in a variety of autoimmune diseases. [17] [18] [19] [20] [28] [29] [30] For example, CD8 T cells are required for the initiation of autoimmune diabetes 18, 19 and are the primary pathogenic effector cells in primary biliary cirrhosis. 17 However, it is also well established that CD8 T cells can have a regulatory role in the context of autoimmunity. 21 In humans with autoimmune diabetes or relapsing-remitting multiple sclerosis, a decrease in the CD8 + CD28suppressor T-cell population has been observed. 22 Additionally, regulatory CD8 T cells have been described in animal models of autoimmune diabetes 25 and in experimental autoimmune encephalomyelitis, 23, 24, 27 the animal model for multiple sclerosis. Thus, evidence exists for both pathogenic and regulatory roles for CD8 T cells in the context of autoimmunity. In Sjögren syndrome, CD8 and CD4 T cells are present in lacrimal and salivary gland infiltrates from both humans and NOD mice. [11] [12] [13] [14] [15] [16] CD4 T cells constitute the major T-cell present in gland infiltrates, and numerous studies have investigated the contributions from these cells in Sjögren syndrome. 40 Yet, despite the consistent presence of CD8 T cells in the lacrimal and salivary glands, it is unclear how these cells contribute to the development or progression of lacrimal gland autoimmunity. Analysis of human lacrimal gland infiltrates from patients with Sjögren syndrome found CD8 T cells clustered around apoptotic acinar epithelial cells, and increased expression of effector molecules was observed, suggesting that the cell death was mediated by CD8 T cells. 11 A recent study found increased activated CD8 T cells in the circulation of Sjögren syndrome patients with higher disease activity. 16 In contrast, a role for regulatory CD8 T cells has been described in a desiccating stress model resembling Sjögren syndrome. 41 However, the role of CD8 T cells in the NOD mouse model of Sjögren syndrome has not been explored previously.
Our study demonstrates that within the lacrimal glands of male NOD mice, CD8 T cells displayed an activated phenotype, produced inflammatory cytokines upon stimulation and expressed markers indicative of cytotoxicity. Using an adoptive transfer model, our study provides evidence that CD8 T cells can independently promote dacryoadenitis and mediate epithelial cell damage. Thus, our data suggest that CD8 T cells have a pathogenic role in lacrimal gland autoimmunity.
The majority of CD8 T cells isolated from the lacrimal and salivary glands of NOD mice produced IFNγ following ex vivo stimulation, suggesting a potential mechanism by which they contribute to disease. IFNγ has multiple biological effects, including immune-cell activation, induction of chemokines and adhesion molecules on immune and nonimmune cells, and promotion of apoptosis. 42 A pathogenic role for IFNγ has been observed in autoimmune diseases such as autoimmune diabetes, 43, 44 systemic lupus erythematosus 45, 46 and rheumatoid arthritis, 42, 47 and elevated levels of IFNγ were reported in Sjögren syndrome patients. 48, 49 In NOD mice, IFNγ was required for the development of salivary gland autoimmunity. 50 IFNγ was shown to alter tight junction integrity and function in parotid gland epithelial cells 51 and to induce salivary gland cell death. 52 Further, the chemokines CXCL9 and CXCL10, which were increased in salivary gland lesions from patients with Sjögren syndrome, were induced by IFNγ in primary salivary gland epithelial cells. 53 Thus, IFNγ likely has a pathogenic role in salivary gland disease through multiple mechanisms. Levels of CXCL9 and CXCL10 were also increased in tears from Sjögren syndrome patients, 54 suggesting that IFNγ may have a similar role in lacrimal gland pathology. Our findings demonstrate that CD8 T cells produce IFNγ and mediate epithelial cell death in NOD mouse lacrimal glands. Thus, IFNγ likely contributes to lacrimal gland pathology through multiple mechanisms.
Because the NOD mouse model displays sex-specific differences in gland inflammation, with dacryoadenitis occurring in male mice and sialadenitis occurring in female mice, 6-10 we independently studied male and female mice for the development of lacrimal and salivary gland disease, respectively. As in the male lacrimal glands, CD8 T cells were present in salivary gland infiltrates from female NOD mice, showed signs of activation and produced inflammatory cytokines. These cytokine-producing T cells were relatively more abundant within lacrimal glands, which may reflect differences in the mechanisms of disease development; however, this could also be explained by differences in the kinetics of lacrimal or salivary gland disease development. More strikingly apparent was the finding that CD8 T cells caused dacryoadenitis when transferred into male recipients, but were completely incapable of mediating sialadenitis in female recipients. Although no difference in lacrimal gland inflammation was noted on a population level between female recipients of purified CD8 T cells and non-CD8+CD8 T cells, we were surprised to find that some female recipients of purified CD8 T cells developed dacryoadenitis with focus scores greater than the median focus scores of male recipients. This is in contrast to NOD female mice or NOD-SCID female recipients of non-CD8+CD8 cells, which develop little or no lacrimal gland autoimmunity. Previously, we have shown that female NOD mice are protected from developing dacryoadenitis because of the presence of lacrimal gland-protective Tregs. 6 One possibility here is that the transfer of purified CD8 T cells, which were largely devoid of Tregs, resulted in dacryoadenitis simply owing to the lack of lacrimal gland-protective Tregs. However, the complete absence of sialadenitis in those same recipients makes this explanation less likely because, in our hands, adoptive transfer of Treg-depleted cells (inclusive of both CD4 and CD8 T cells) results in both dacryoadenitis and sialadenitis in recipients regardless of sex (manuscript in preparation). Thus, our studies demonstrate a unique role for CD8 T cells in mediating lacrimal gland-specific inflammation in the absence of CD4 T cells.
Our studies expand previous findings that distinct mechanisms drive lacrimal and salivary gland autoimmunity. Differences in gland infiltration have been observed in NOD mice that are deficient for IFNγ or IFNγR expression. 50 In this context, focal infiltrates in the salivary glands of NOD.IFNγ -/or NOD.IFNγR -/mice were absent at 20 weeks of age, similar to the salivary glands from non-autoimmune, age-matched C57BL/6 mice, and in contrast to the parental NOD strain. However, leukocyte infiltrates were still observed in the lacrimal glands of NOD.IFNγ -/or NOD.IFNγR -/mice at levels similar to that observed in NOD mice. 50 Additionally, distinct susceptibility loci were linked to the development of dacryoadenitis and sialadenitis in the MRL/lpr mouse model of Sjögren syndrome. 55 Thus, evidence from our study and others suggests that inflammation of the lacrimal and salivary glands can arise through distinct mechanisms.
In our adoptive transfer studies, we observed variability in disease development with some recipients failing to develop lacrimal gland inflammation. This is similar to the variability we have previously observed in this adoptive transfer model 6 and likely reflects multiple factors. We developed this adoptive transfer model to study the early immunological events in lacrimal and salivary gland autoimmunity and believe the lack of all recipients being affected by 5-7 weeks post transfer is indicative of such an early stage in disease development. Sjögren syndrome-like disease in NOD mice is an immunologically complex disease as reflected by the variability in degree of lacrimal gland inflammation even in the spontaneous disease. 6 In that study, spontaneous disease in 6-12-week-old male NOD mice demonstrated variable focus scores; however, all mice in that analysis had developed some degree of dacryoadenitis and, in general, the focus scores in spontaneous disease were greater than those in the adoptive transfer model. It is unclear whether these differences in the transfer and spontaneous models suggest that the transfer model represents a very early stage in disease development or, rather, that other factors contributing to spontaneous disease development are not optimized in the transfer model. Regardless, it is striking that despite the variability in disease development in our adoptive transfer model, our data clearly demonstrate a pathogenic role for CD8 T cells in lacrimal gland autoimmunity including a role in mediating lacrimal gland epithelial cell death. Beyond the lacrimal glands, the ocular surface is another key site of inflammatory damage in Sjögren syndrome. Whether the pathogenic role for CD8 T cells extends similarly to the ocular surface in NOD mice was not evaluated in our studies. Interestingly, studies in a desiccating stress model demonstrated a regulatory role for CD8 T cells at the ocular surface, so further studies into the role of CD8 T cells in ocular surface inflammation in NOD mice are warranted.
In addition to a pathogenic role for CD8 T cells, our studies here also further support the key role of CD4 T cells in lacrimal gland autoimmunity as evidenced by the outgrowth of CD4 T cells and their enrichment within lacrimal glands in our CD8-only transfer studies. Because we focused on CD8 T cells in these studies, we did not evaluate for phenotypic differences in the outgrowing CD4 T-cell population compared with CD4 T cells in non-CD8+CD8 transfers, non-CD8 transfers or spontaneous disease. Further study of these CD4 T-cell populations may provide insight into the specific mechanisms of pathogenic CD4 T-cell involvement in lacrimal gland autoimmunity. Regardless, our data demonstrate that even when the outgrowth of CD4 T cells is prevented, CD8 T cells are capable of mediating lacrimal gland autoimmunity.
Understanding the initiation of a complex autoimmune disease such as Sjögren syndrome requires knowledge of all of the cellular players involved in the immune response. Our work here describes a pathogenic role for CD8 T cells in the early stages of dacryoadenitis. Further insight into the mechanisms that are required for CD8 T cells to overcome immune tolerance will help in understanding the events that lead to the development of organ-specific autoimmunity.
METHODS Mice
Male and female NOD/ShiLtJ (NOD), NOD.CB17-Prkdc scid /J (NOD-SCID), NOD.129S6(B6)-CD4 tm1knw /DvsJ (CD4 null ) and Balb/cJ mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). Male and female NOD.129S2(B6)-CD8a tm1Mak /DvsJ (CD8 null ) mice were kindly provided by David Serreze (The Jackson Laboratory). NOD mice expressing the bicistronic Foxp3-green fluorescent protein (NOD), obtained by backcrossing the Foxp3-green fluorescent protein knock-in C57BL/6 J mice 56 for 420 generations onto the NOD background, were a kind gift from Vijay Kuchroo (Harvard University, Cambridge, MA, USA). For transfer studies, donor mice were 5-6 weeks old and recipients were 7-9 weeks old. For ex vivo analyses, mice were 12-17 weeks old. The exact sample size (n) and biological and experimental replicates are indicated in each figure legend. Samples sizes were determined based on previous transfer studies and typically included 10-15 mice per group pooled from multiple experiments. All mice were monitored for the presence of glucosuria using Diastix urine dipsticks (Bayer Diagnostics, Whippany, NJ, USA). A positive test was indicative of autoimmune diabetes development. Mice were maintained and used in accordance with the University of Iowa Institutional Animal Care and Use Committee Guidelines.
Histological characterization of inflammation in lacrimal and salivary glands
Exorbital lacrimal and submandibular salivary glands were harvested and fixed in buffered formalin, processed, embedded in paraffin and sectioned. Five micrometer sections of paired glands were stained with hematoxylin and eosin and analyzed by standard light microscopy. Inflammation was quantified using standard focus scoring. 57 Focus scores (number of inflammatory foci per 4 mm 2 ) were calculated by a blinded observer by counting the total number of foci (composed of ⩾ 50 mononuclear cells) by standard light microscopy using a x10 objective, scanning slides to obtain digital images using PathScan Enabler IV (Meyer Instruments, Houston, TX, USA), and measuring surface area of sections using the ImageJ software (US National Institutes of Health, Bethesda, MD, USA). 58 Samples with diffuse inflammation resulting in coalescence of individual foci were assigned focus score values greater than the highest calculable value for that set of comparisons. Representative images were captured on a Leitz DM-RB research microscope with a Leica DCF700T digital camera using the Leica Application Suite X software (Leica Microsystems, Wetzlar, Germany).
Lymphocyte isolation
Cervical LN or spleens were dissociated with the end of a 3 ml syringe plunger through 70 μM nylon mesh in RPMI (Life Technologies, Waltham, MA, USA) supplemented with 10% fetal bovine serum, 100 U ml − 1 penicillin, 100 μg ml − 1 streptomycin and 50 μM β-mercaptoethanol (complete RPMI). Cells were treated with ACK lysis buffer (Lonza, Mapleton, IL, USA) to remove red blood cells. To isolate cells from the lacrimal or salivary glands, glands were incubated in Collagenase type IV (Life Technologies, Waltham, MA, USA) at 37°C with shaking for 1 or 1.5 h, respectively. Glands were then dissociated with the end of a 3 ml syringe plunger through 40 μM nylon mesh and red blood cell lysed as above to obtain single-cell suspensions. Peripheral blood samples were collected through the retro-orbital plexus and diluted in phosphate-buffered saline containing 20 U ml − 1 heparin sodium (Fisher Scientific, Hampton, NH, USA). Single-cell suspensions were obtained using Histopaque-1083 (Sigma-Aldrich, St Louis, MO, USA) according to the manufacturer's instructions.
Flow cytometry and FACS
Cells from cervical LN, lacrimal or salivary glands, or peripheral blood were analyzed by flow cytometry using a BD LSR II or BD Acurri C6 (BD Biosciences, San Jose, CA, USA) for acquisition and the FlowJo software (Treestar Inc., Ashland, OR, USA) for analysis. All samples were gated initially on forward and side scatter parameters to establish the lymphocyte gate and then on forward scatter-area by forward scatter-width to establish singlet gates. Specific additional gating was noted in figure legends. For live/dead discrimination, cells were stained with a fixable viability dye from eBioscience (San Diego, CA, USA). Intracellular staining was performed using the Foxp3/transcription factor staining buffer set according to the manufacturer's instructions (eBioscience). For CD8-based FACSorting, cells were labeled with a fluorophore-conjugated anti-CD8α monoclonal antibody and sorted into CD8 + and CD8populations using a FACS Aria. For analyses of peripheral blood cells from mice treated with anti-CD4 antibody (GK1.5), staining was performed using a different anti-CD4 antibody clone (RM4-5). For cytokine analyses, cells were stimulated for 4 h at 37°C with Leukocyte Activation Cocktail (with BD GolgiPlug) plus monensin (BD Biosciences) in complete RPMI followed by surface and intracellular staining. For CD107a analysis, cells were stimulated as for cytokine analysis, with the anti-CD107a antibody included during cell stimulation. 59 Antibodies were purchased from BD Biosciences, BioLegend (San Diego, CA, USA) or eBioscience. Antibody clones used were as follows: CD3ε (145-2c11), CD4 (GK1.5 or RM4-5), CD8α (53-6.7), CD11a (2D7), CD69 (H1.2F3), CD107a (1D4B), IFNγ (XMG1.2), Foxp3 (FJK-16s), Ki67 (SolA15) and tumor necrosis factor α (MP6 XT22). Anti-human granzyme B (GB12) was obtained from Life Technologies.
Transfer model of Sjögren syndrome
Donor cells were isolated from cervical LNs (mandibular, accessory mandibular and superficial parotid), 60 pooled from several sex-matched NOD mice and adoptively transferred intravenously to sex-matched NOD-SCID recipients. Recipients of different donor cell groups were randomly assigned with each cage housing recipients from multiple groups to avoid a cage effect. Transferred cells included 1.5-2 × 10 6 purified CD8 T cells (CD8-only), 5 × 10 6 CD8-depleted cells (non-CD8) or a combination of 1.5-2 × 10 6 CD8-only and 5 × 10 6 non-CD8 (non-CD8+CD8). After 5-7 weeks, organs were harvested for histology and/or flow cytometric analysis. For anti-CD4 treatment, mice received weekly intraperitoneal injections of 100 μg of anti-CD4 antibody (GK1.5) or isotype control antibody (rat IgG2b anti-KLH) (BioXcell, Lebanon, NH, USA) beginning at the time donor cells were transferred. All donors and recipients tested negative for glucosuria at the time of killing for tissue harvesting.
Activated caspase-3 staining
Activated caspase-3 immunostaining, which is a recommended and validated technique for detecting and quantifying apoptotic cells in tissue sections, [61] [62] [63] [64] [65] [66] was performed similar to previous methods. 66 Briefly, paraffin-embedded tissues were sectioned (~4 μm) onto slides, and hydrated through a series of xylene and alcohol baths. Epitope unmasking was performed using heatinduced antigen retrieval (citrate buffer (pH 6.0), 125°C × 25 min). Primary antibody was a rabbit polyclonal antibody (1:100, cat. no. 9661; Cell Signaling Technologies, Danvers, MA, USA). 3,3′-Diaminobenzidine was the chromogen, and hematoxylin was the counterstain. Activated caspase-3 staining was quantified using a postexamination masking technique to mitigate bias. 67 Briefly, high-resolution images at x200 magnification were collected using a BX51 microscope, DP53 camera and CellSens Software (Olympus Corporation, Center Valley, PA, USA). A defined total area of 0.92 mm 2 was analyzed for each image. Only images in which the entire focus could be observed within the specified area were used for analyses. In a minority of cases, foci were too large to fit in the specified field of view, and these images were excluded from the analysis. Analysis of each image included counting the number of cells staining positive for activated caspase-3 staining and noting the location of each positive cell as either within the inflammatory cell focus (in), outside the inflammatory cell focus but within the specified field of view (out) or in a control image that did not include and was not contiguous to inflammatory cell foci (normal). For each gland, the average number of activated caspase-3 + cells was obtained from two images. For whole-section activated caspase-3 + cell quantitation, the number of activated caspase-3 + cells within whole tissue sections from paired glands was obtained. For each sample, the number of activated caspase-3 + cells was enumerated and normalized to total tissue section area to obtain the number of activated caspase-3 + cells per mm 2 . These data were then used in correlation analyses to determine the degree of correlation to the number of foci per mm 2 obtained from hematoxylin-and eosin-stained sections from the same tissue samples. All analyses were carried out in a masked manner.
Statistical analysis
Statistical analyses were performed with Prism software version 6.0 (GraphPad, San Diego, CA, USA) or R version 3.3.2 (R Foundation for Statistical Computing, Vienna, Austria). Mann-Whitney U-test was used for two-group comparisons of non-normally distributed data (focus scores). Unpaired Student's t-test was used for two-group comparisons of data that approximated normal distribution (flow cytometry data). Welch's correction was applied to comparisons with significant differences in variance. All two-group comparisons were two-tailed. Two-way ANOVA was used for two-dimensional analyses. For two-dimensional analyses of non-normally distributed data, the observed data values were converted to ranks, two-way ANOVA was performed on those ranks, and Tukey's honest significant difference post hoc test was used to control the α-level for multiple comparisons. Visual inspection of the residuals yielded no evidence of any model assumptions being violated. Pearson's correlation coefficient was calculated for correlation analysis of normally distributed data. Spearman's correlation coefficient was calculated for correlation analysis of non-normally distributed data. P-values o0.05 were considered significant.
